Yang Li, Zeng Xiao-Tao, Luo Rong-Hua, Tang Ying, Ren Si-Xue, Long Xin-Yan, Fu Xiang-Hui, Zhang Wan-Jiang, Ren Hai-Yan, Zheng Yong-Tang, Cheng Wei
Department of Pulmonary and Critical Care Medicine, Respiratory Infection and Intervention Laboratory of Frontiers Science Center for Disease-related Molecular Network, and State Key Laboratory of Biotherapy, West China Hospital of Sichuan University, Chengdu 610041, China.
Department of Pulmonary and Critical Care Medicine, Respiratory Infection and Intervention Laboratory of Frontiers Science Center for Disease-related Molecular Network, and State Key Laboratory of Biotherapy, West China Hospital of Sichuan University, Chengdu 610041, China; Research and Innovation Center, Pengzhou People's Hospital, Pengzhou 610000, China.
Virol Sin. 2025 Feb;40(1):92-108. doi: 10.1016/j.virs.2024.12.006. Epub 2024 Dec 28.
Virus-encoding RNA-dependent RNA polymerase (RdRp) is essential for genome replication and gene transcription of human coronaviruses (HCoVs), including severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We previously identified the interaction between the catalytic subunit NSP12 of SARS-CoV-2 RdRp and the host protein CREB-regulated transcription coactivator 3 (CRTC3), a member of the CRTC family that regulates cyclic AMP response element-binding protein (CREB)-mediated transcriptional activation. Currently, the implication of CRTC3 in the pathogenesis of HCoVs is poorly understood. Herein, we demonstrated that CRTC3 attenuates RdRp activity and SARS-CoV-2 genome replication, therefore reducing the production of progeny viruses. The interaction of CRTC3 with NSP12 contributes to its inhibitory effect on RdRp activity. Furthermore, we expanded the suppressive effects of two other CRTC family members (CRTC1 and CRTC2) on the RdRp activities of lethal HCoVs, including SARS-CoV-2 and Middle East respiratory syndrome coronavirus (MERS-CoV), along with the CREB antagonization. Overall, our research suggests that CRTCs restrict the replication of HCoVs and are antagonized by CREB, which not only provides new insights into the replication regulation of HCoVs, but also offers important information for the development of anti-HCoV interventions.
病毒编码的RNA依赖性RNA聚合酶(RdRp)对于人类冠状病毒(HCoV)的基因组复制和基因转录至关重要,包括严重急性呼吸综合征冠状病毒2(SARS-CoV-2)。我们先前鉴定了SARS-CoV-2 RdRp的催化亚基NSP12与宿主蛋白CREB调节的转录共激活因子3(CRTC3)之间的相互作用,CRTC3是CRTC家族的成员,可调节环磷酸腺苷反应元件结合蛋白(CREB)介导的转录激活。目前,人们对CRTC3在HCoV发病机制中的作用了解甚少。在此,我们证明CRTC3可减弱RdRp活性和SARS-CoV-2基因组复制,从而减少子代病毒的产生。CRTC3与NSP12的相互作用有助于其对RdRp活性的抑制作用。此外,我们扩展了另外两个CRTC家族成员(CRTC1和CRTC2)对致死性HCoV(包括SARS-CoV-2和中东呼吸综合征冠状病毒(MERS-CoV))的RdRp活性的抑制作用,以及对CREB的拮抗作用。总体而言,我们的研究表明CRTCs限制了HCoV的复制,并受到CREB的拮抗,这不仅为HCoV的复制调控提供了新见解,也为抗HCoV干预措施的开发提供了重要信息。